Drug intelligence / Profile preview

YHP2401

Development stage
Phase 3
Lead developer
Yuhan
Modality
Small Molecules
Administration
Oral
01

Overview

YHP2401 is an investigational pharmaceutical drug developed by Yuhan Corporation, currently undergoing **phase 3 clinical trials** as a treatment for **acute bronchitis** in adults[1][2][5]. Details regarding its chemical composition, mechanism of action, and exact formulation have not been publicly disclosed, but it is positioned as a potential new therapy being compared against standard bronchitis treatments (YHR2402 and YHR2403) in multicenter, randomized, double-blind, active-controlled clinical studies[1][5]. The drug appears to be administered as a single agent (not a combination), intended to address productivity cough and related acute bronchitis symptoms.

Brand names
YHP2401YHP-2401YHP 2401
Other names
YHP2401YHP-2401YHP 2401
02

Targets

IL-6 (Interleukin 6)NF-κBIL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on YHP2401.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on YHP2401.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call